Sfoglia per Autore
Heat-shock protein 27 (HSP27, HSPB1) is up-regulated by MET kinase inhibitors and confers resistance to MET-targeted therapy.
2014-01-01 Musiani, Daniele; Konda, John David; Pavan, Simona; Torchiaro, Erica; Sassi, Francesco; Noghero, Alessio; Erriquez, Jessica; Perera, Timothy; Olivero, Martina; Di Renzo, Maria Flavia
AKT activation drives the nuclear localization of CSE1L and a pro-oncogenic transcriptional activation in ovarian cancer cells.
2013-01-01 Lorenzato A;Biolatti M;Delogu G;Capobianco G;Farace C;Dessole S;Cossu A;Tanda F;Madeddu R;Olivero M;Di Renzo MF
IRF-1 expression is induced by cisplatin in ovarian cancer cells and limits drug effectiveness.
2013-01-01 Pavan S;Olivero M;Corà D;Di Renzo MF
Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas
2013-01-01 Maniscalco, L; Millán, Y; Iussich, S; Denina, M; Sánchez-Céspedes, R; Gattino, F; Biolatti, B; Sasaki, N; Nakagawa, T; Di Renzo, Mf; de Las Mulas, Jm; De Maria, R.
HSP27 is Involved in Ovarian Cancer Cell Motility and Response to Paclitaxel
2012-01-01 Pavan S ; Musiani D ; Torchiaro E ; Migliardi G ; Olivero M; Di Renzo MF
Inhibition of P90RSK Sensitizes Ovarian Cancer Cells to Apoptosis
2012-01-01 Torchiaro E ; Olivero M ; Pavan S ; Di Renzo MF
The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors
2012-01-01 Dani N; Olivero M; Mareschi K; van Duist MM; Miretti S; Cuvertino S; Patanè S; Calogero R; Ferracini R; Scotlandi K; Fagioli F; Di Renzo MF
Cells lacking the fumarase tumor suppressor are protected from apoptosis through a HIF-independent, AMPK dependent mechanism.
2012-01-01 Bardella C;Olivero M;Lorenzato A;Geuna M;Adam J;O'Flaherty L;Rustin P;Tomlinson I;Pollard PJ;Di Renzo MF
The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C
2012-01-01 Lorenzato A; Martino C; Dani N; Oligschläger Y; Ferrero AM; Biglia N; Calogero R; Olivero M; Di Renzo MF.
Daily administration of low molecular weight heparin increases Hepatocyte Growth Factor serum levels in gynaecological patients: pharmacokinetic parameters and clinical implications.
2012-01-01 Surbone A; Fuso L; Passera R; Ferrero A; Marchese C; Martino C; Luchin A; Di Renzo MF; Zola P.
DNA damage stress phenotype makes cancer cells addicted to a redundant CUL4 dependent pathway
2011-01-01 Olivero M; Dettori D; Pavan S; Di Renzo MF
The cellular apoptosis susceptibility CAS/CSE1L gene specifically protects ovarian cancer cells from death by suppressing RASSF1C
2011-01-01 Lorenzato A; Martino C; Olivero M; Dani N; Oligschläger Y; Ferrero AM; Biglia N; Calogero R; Di Renzo MF
Genetic and expression analysis of MET, MACC1 and HGF in metastatic colorectal cancer: Response to Met inhibition in patient xenografts and pathological correlations
2011-01-01 Francesco Galimi; Davide Torti; Francesco Sassi; Claudio Isella; Davide Corà; Stefania Gastaldi; Dario Ribero; Andrea Muratore; Paolo Massucco; Dimitrios Siatis; Gianluca Paraluppi; Federica Gonella; Francesca Maione; Alberto Pisacane; Ezio David; Bruno Torchio; Mauro Risio; Mauro Salizzoni; Lorenzo Capussotti; Tim Perera; Enzo Medico; M.F. Di Renzo; Paolo M. Comoglio; Livio Trusolino*; Andrea Bertotti* (*Co-Senior Authors)
The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors
2011-01-01 Dani N; Olivero M; Mareschi K; Calogero R; Ferracini R; Scotlandi K; Fagioli F; Di Renzo MF
Fumarase tumor suppressor gene and MET oncogene cooperate in upholding transformation and tumorigenesis.
2010-01-01 Costa B; Dettori D; Lorenzato A; Bardella C; Coltella N; Martino C; Cammarata C; Carmeliet P; Olivero M; Di Renzo MF
Expression Profiling in Progressive Stages of Fumarate-Hydratase Deficiency: The Contribution of Metabolic Changes to Tumorigenesis.
2010-01-01 Ashrafian H; O'Flaherty L; Adam J; Steeples V; Chung YL; East P; Vanharanta S; Lehtonen H; Nye E; Hatipoglu E; Miranda M; Howarth K; Shukla D; Troy H; Griffiths J; Spencer-Dene B; Yusuf M; Volpi E; Maxwell PH; Stamp G; Poulsom R; Pugh CW; Costa B; Bardella C; Di Renzo MF; Kotlikoff MI; Launonen V; Aaltonen L; El-Bahrawy M; Tomlinson I; Pollard PJ.
MET-ONCOGENE TRANSFORMS HUMAN PRIMARY BONE-DERIVED CELLS BY TARGETING OSTEOPROGENITORS
2010-01-01 N Dani; M Olivero; S Patane; M VanDuist; K Mareschi(1); F Fagioli(1); Di Renzo MF
CSE1L as a Potential Target to Sensitize Ovarian Cancer Cells to Cisplatin
2010-01-01 Lorenzato A; Olivero M; Calogero R., Martino C, Musiani D, Dani N, Di Renzo MF
Cells lacking fumarase are protected from apoptosis through a HIF independent, AMPK dependent mechanism
2010-01-01 Di Renzo MF
Atlante di Istologia e Anatomia Microscopica
2010-01-01 Calligaro A; Di Renzo MF
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Heat-shock protein 27 (HSP27, HSPB1) is up-regulated by MET kinase inhibitors and confers resistance to MET-targeted therapy. | 2014 | Musiani, Daniele; Konda, John David; Pavan, Simona; Torchiaro, Erica; Sassi, Francesco; Noghero, Alessio; Erriquez, Jessica; Perera, Timothy; Olivero, Martina; Di Renzo, Maria Flavia | |
| AKT activation drives the nuclear localization of CSE1L and a pro-oncogenic transcriptional activation in ovarian cancer cells. | 2013 | Lorenzato A;Biolatti M;Delogu G;Capobianco G;Farace C;Dessole S;Cossu A;Tanda F;Madeddu R;Olivero M;Di Renzo MF | |
| IRF-1 expression is induced by cisplatin in ovarian cancer cells and limits drug effectiveness. | 2013 | Pavan S;Olivero M;Corà D;Di Renzo MF | |
| Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas | 2013 | Maniscalco, L; Millán, Y; Iussich, S; Denina, M; Sánchez-Céspedes, R; Gattino, F; Biolatti, B; Sasaki, N; Nakagawa, T; Di Renzo, Mf; de Las Mulas, Jm; De Maria, R. | |
| HSP27 is Involved in Ovarian Cancer Cell Motility and Response to Paclitaxel | 2012 | Pavan S ; Musiani D ; Torchiaro E ; Migliardi G ; Olivero M; Di Renzo MF | |
| Inhibition of P90RSK Sensitizes Ovarian Cancer Cells to Apoptosis | 2012 | Torchiaro E ; Olivero M ; Pavan S ; Di Renzo MF | |
| The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors | 2012 | Dani N; Olivero M; Mareschi K; van Duist MM; Miretti S; Cuvertino S; Patanè S; Calogero R; Ferracini R; Scotlandi K; Fagioli F; Di Renzo MF | |
| Cells lacking the fumarase tumor suppressor are protected from apoptosis through a HIF-independent, AMPK dependent mechanism. | 2012 | Bardella C;Olivero M;Lorenzato A;Geuna M;Adam J;O'Flaherty L;Rustin P;Tomlinson I;Pollard PJ;Di Renzo MF | |
| The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C | 2012 | Lorenzato A; Martino C; Dani N; Oligschläger Y; Ferrero AM; Biglia N; Calogero R; Olivero M; Di Renzo MF. | |
| Daily administration of low molecular weight heparin increases Hepatocyte Growth Factor serum levels in gynaecological patients: pharmacokinetic parameters and clinical implications. | 2012 | Surbone A; Fuso L; Passera R; Ferrero A; Marchese C; Martino C; Luchin A; Di Renzo MF; Zola P. | |
| DNA damage stress phenotype makes cancer cells addicted to a redundant CUL4 dependent pathway | 2011 | Olivero M; Dettori D; Pavan S; Di Renzo MF | |
| The cellular apoptosis susceptibility CAS/CSE1L gene specifically protects ovarian cancer cells from death by suppressing RASSF1C | 2011 | Lorenzato A; Martino C; Olivero M; Dani N; Oligschläger Y; Ferrero AM; Biglia N; Calogero R; Di Renzo MF | |
| Genetic and expression analysis of MET, MACC1 and HGF in metastatic colorectal cancer: Response to Met inhibition in patient xenografts and pathological correlations | 2011 | Francesco Galimi; Davide Torti; Francesco Sassi; Claudio Isella; Davide Corà; Stefania Gastaldi; Dario Ribero; Andrea Muratore; Paolo Massucco; Dimitrios Siatis; Gianluca Paraluppi; Federica Gonella; Francesca Maione; Alberto Pisacane; Ezio David; Bruno Torchio; Mauro Risio; Mauro Salizzoni; Lorenzo Capussotti; Tim Perera; Enzo Medico; M.F. Di Renzo; Paolo M. Comoglio; Livio Trusolino*; Andrea Bertotti* (*Co-Senior Authors) | |
| The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors | 2011 | Dani N; Olivero M; Mareschi K; Calogero R; Ferracini R; Scotlandi K; Fagioli F; Di Renzo MF | |
| Fumarase tumor suppressor gene and MET oncogene cooperate in upholding transformation and tumorigenesis. | 2010 | Costa B; Dettori D; Lorenzato A; Bardella C; Coltella N; Martino C; Cammarata C; Carmeliet P; Olivero M; Di Renzo MF | |
| Expression Profiling in Progressive Stages of Fumarate-Hydratase Deficiency: The Contribution of Metabolic Changes to Tumorigenesis. | 2010 | Ashrafian H; O'Flaherty L; Adam J; Steeples V; Chung YL; East P; Vanharanta S; Lehtonen H; Nye E; Hatipoglu E; Miranda M; Howarth K; Shukla D; Troy H; Griffiths J; Spencer-Dene B; Yusuf M; Volpi E; Maxwell PH; Stamp G; Poulsom R; Pugh CW; Costa B; Bardella C; Di Renzo MF; Kotlikoff MI; Launonen V; Aaltonen L; El-Bahrawy M; Tomlinson I; Pollard PJ. | |
| MET-ONCOGENE TRANSFORMS HUMAN PRIMARY BONE-DERIVED CELLS BY TARGETING OSTEOPROGENITORS | 2010 | N Dani; M Olivero; S Patane; M VanDuist; K Mareschi(1); F Fagioli(1); Di Renzo MF | |
| CSE1L as a Potential Target to Sensitize Ovarian Cancer Cells to Cisplatin | 2010 | Lorenzato A; Olivero M; Calogero R., Martino C, Musiani D, Dani N, Di Renzo MF | |
| Cells lacking fumarase are protected from apoptosis through a HIF independent, AMPK dependent mechanism | 2010 | Di Renzo MF | |
| Atlante di Istologia e Anatomia Microscopica | 2010 | Calligaro A; Di Renzo MF |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile